These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36647979)

  • 1. Hepatocyte Growth Factor in Predialysis and Hemodialysis Chronic Kidney Disease Patients.
    Vulugundam SC; Kiranmayi VS; Rao PVLNS; Vishnubhotla SK
    Saudi J Kidney Dis Transpl; 2022; 33(1):58-65. PubMed ID: 36647979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum hepatocyte growth factor is associated with truncal fat mass and increased mortality in chronic kidney disease stage 5 patients with protein-energy wasting.
    Yuan J; Watanabe M; Suliman M; Qureshi AR; Axelsson J; Bárány P; Heimbürger O; Stenvinkel P; Lindholm B
    Nephrol Dial Transplant; 2015 Feb; 30(2):274-82. PubMed ID: 23975839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in cardiac structure assessed by echocardiography between renal transplant recipients and chronic kidney disease patients.
    Dounousi E; Mitsis M; Naka KK; Pappas C; Lakkas L; Harisis C; Pappas K; Koutlas V; Tzalavra I; Spanos G; Michalis LK; Siamopoulos KC
    Transplant Proc; 2014 Nov; 46(9):3194-8. PubMed ID: 25420857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte Growth Factor-Secreting Mesothelial Cell Sheets Suppress Progressive Fibrosis in a Rat Model of CKD.
    Oka M; Sekiya S; Sakiyama R; Shimizu T; Nitta K
    J Am Soc Nephrol; 2019 Feb; 30(2):261-276. PubMed ID: 30635373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of abdominal aortic calcification in predialysis chronic kidney disease and maintenance hemodialysis patients.
    Dhakshinamoorthy J; Elumalai RP; Dev B; Hemamalini AJ; Venkata Sai PM; Periasamy S
    Saudi J Kidney Dis Transpl; 2017; 28(6):1338-1348. PubMed ID: 29265045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of abdominal aortic calcification at different stages of chronic kidney disease.
    Biyik Z; Selcuk NY; Tonbul HZ; Anil M; Uyar M
    Int Urol Nephrol; 2016 Dec; 48(12):2061-2068. PubMed ID: 27620901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of Oxidative Stress, Inflammation, and Endothelial Dysfunction in Diabetic and Nondiabetic Patients with Chronic Kidney Disease on Peritoneal Dialysis.
    Nannapaneni SS; Nimmanapalli HD; Lakshmi AY; Vishnubotla SK
    Saudi J Kidney Dis Transpl; 2022; 33(3):361-372. PubMed ID: 37843137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher Serum Hepatocyte Growth Factor Concentration is Associated with Better Preservation of GFR in Hemodialysis Patients.
    Baum E; Maćkowiak B; Sosińska-Zawierucha P; Pawlaczyk K; Kołodziejczak B; Breborowicz A
    Kidney Blood Press Res; 2017; 42(6):1175-1182. PubMed ID: 29227979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of biomarkers of inflammation and oxidative stress with the risk of chronic kidney disease in Type 2 diabetes mellitus in North Indian population.
    Gupta S; Gambhir JK; Kalra O; Gautam A; Shukla K; Mehndiratta M; Agarwal S; Shukla R
    J Diabetes Complications; 2013; 27(6):548-52. PubMed ID: 24012111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte growth factor predicts survival and relates to inflammation and intima media thickness in end-stage renal disease.
    Malatino LS; Mallamaci F; Benedetto FA; Bellanuova I; Cataliotti A; Tripepi G; Zoccali C
    Am J Kidney Dis; 2000 Nov; 36(5):945-52. PubMed ID: 11054350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of, and Preparations for, Dialysis.
    Gondal M
    Med Clin North Am; 2023 Jul; 107(4):681-687. PubMed ID: 37258006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-sectional Study of Calcium Phosphate Product and Intact Parathyroid Hormone Levels in Predialysis and Postdialysis Patients with Stage 5 Chronic Kidney Disease.
    Rastogi A; Kumar S; Kumar R; Singh AK; Kumar C; Prakash G
    Saudi J Kidney Dis Transpl; 2021; 32(4):967-972. PubMed ID: 35229793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear Respiratory Factor-1 (NRF-1) Gene Expression in Chronic Kidney Disease Patients Undergoing Hemodialysis and Mitochondrial Oxidative Dysregulation.
    Hashad D; Elgohry I; Dwedar F
    Clin Lab; 2016 Nov; 62(11):2149-2154. PubMed ID: 28164673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive acute-phase inflammatory markers in different stages of chronic kidney disease.
    Romão JE; Haiashi AR; Elias RM; Luders C; Ferraboli R; Castro MC; Abensur H
    Am J Nephrol; 2006; 26(1):59-66. PubMed ID: 16508248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum hepatocyte growth factor levels in patients with chronic renal failure.
    Sugimura K; Kim T; Goto T; Kasai S; Takemoto Y; Matsuda J; Yoshimoto M; Yamagami S; Kishimoto T
    Nephron; 1995; 70(3):324-8. PubMed ID: 7477621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodialysis prevents liver disease caused by hepatitis C virus: role of hepatocyte growth factor.
    Rampino T; Arbustini E; Gregorini M; Guallini P; Libetta C; Maggio M; Ranghino A; Silini E; Soccio G; Dal Canton A
    Kidney Int; 1999 Dec; 56(6):2286-91. PubMed ID: 10594807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory markers and hepatocyte growth factor in sustained hemodialysis hypotension.
    Lee CT; Hsu CY; Lam KK; Lin CR; Chen JB
    Artif Organs; 2005 Dec; 29(12):980-3. PubMed ID: 16305655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial function and oxidative stress in chronic kidney disease of varying severity and the effect of acute hemodialysis.
    Khaira A; Mahajan S; Kumar A; Saraya A; Tiwari SC; Prakash S; Gupta A; Bhowmik D; Agarwal SK
    Ren Fail; 2011; 33(4):411-7. PubMed ID: 21529270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship Between SCUBE1 Levels and Echocardiography and Electrocardiography Findings and Epicardial Adipose Tissue/Carotid Intima-Media Thickness in Patients Receiving Renal Replacement Therapy.
    Ayan H; Akilli R; Kaya B; Paydas S; Kara E; Cureoglu A
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):181-187. PubMed ID: 30777551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctional Natural Polymer Nanoparticles as Antifibrotic Gene Carriers for CKD Therapy.
    Midgley AC; Wei Y; Zhu D; Gao F; Yan H; Khalique A; Luo W; Jiang H; Liu X; Guo J; Zhang C; Feng G; Wang K; Bai X; Ning W; Yang C; Zhao Q; Kong D
    J Am Soc Nephrol; 2020 Oct; 31(10):2292-2311. PubMed ID: 32769144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.